Ranibizumab in the Treatment of Chronic Central Serous Chorio Retinopathy

Advances in Ophthalmology & Visual System
doi 10.15406/aovs.2017.06.00196
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MedCrave Group, LLC

Related search

Argon Laser Photocoagulation in the Treatment of Central Serous Retinopathy.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1979English

Foveal Cone Photopigment Bleaching in Central Serous Retinopathy

Applied Optics
1988English

Photostress Recovery Times in Cases of Central Serous Retinopathy

Journal of the Royal Society of Medicine
Medicine
1980English

Detection of Retinal Metabolic Stress Resulting From Central Serous Retinopathy

Retina
MedicineOphthalmology
2009English

Evidence to Date: Ranibizumab and Its Potential in the Treatment of Retinopathy of Prematurity

Eye and Brain
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Role of Optical Coherence Tomography in Diagnosis and Management of Central Serous Retinopathy

Journal of Evidence Based Medicine and Healthcare
2018English

Comparison of Intravitreal Ranibizumab and Bevacizumab Treatment for Retinopathy of Prematurity

Arquivos Brasileiros de Oftalmologia
MedicineOphthalmology
2015English

Three Consecutive Monthly Intravitreal Ranibizumab for Choroidal Neovascularization in Central Serous Choriorethinopathy: A Case Report

Open Journal of Ophthalmology
2012English

Exome Sequencing in Families With Chronic Central Serous Chorioretinopathy

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy